Bell's palsy in children: Current treatment patterns in Australia and New Zealand. A PREDICT study

Franz E Babl1,2,3, Kaya K Gardiner2, Amit Kochar4

  • 1Emergency Department, Royal Children's Hospital, Melbourne, Victoria, Australia.

Insights

Pediatric Bell's palsy treatment varies in Australasian emergency departments. Prednisolone is frequently used, and this study confirms the feasibility of a randomized controlled trial (RCT) for its effectiveness in children.

Area of Science:

  • Pediatric Neurology
  • Emergency Medicine
  • Clinical Trials

Background:

  • Bell's palsy etiology and clinical course may differ between pediatric and adult patients.
  • There is a lack of randomized placebo-controlled trials (RCTs) demonstrating the effectiveness of prednisolone for pediatric Bell's palsy.
  • Current treatment practices for pediatric Bell's palsy in Australasian Emergency Departments (EDs) are not well-documented.

Purpose of the Study:

  • To assess current management practices for pediatric Bell's palsy in Australian and New Zealand Emergency Departments (EDs).
  • To determine the feasibility of conducting a multicenter RCT for pediatric Bell's palsy within the Paediatric Research in Emergency Departments International Collaborative (PREDICT) network.

Main Methods:

  • A retrospective analysis of ED medical records for children under 18 diagnosed with Bell's palsy between January 1, 2012, and December 31, 2013.
  • Data collection included presentation details, diagnosis, and management, entered into an online database (REDCap).
  • Searches used Bell's palsy related terms, excluding repeat presentations for the same illness but including relapses.

Main Results:

  • 323 presentations were analyzed from 14 PREDICT sites, with a mean age of 9.0 years (57.0% female).
  • Most children (73.7%) presented within 72 hours of symptom onset; 52.0% had seen a doctor previously.
  • Steroids were administered in 67.5% of cases, with prednisolone commonly prescribed (9 days, ~1 mg/kg/day, with tapering in 35.7%).

Conclusions:

  • Treatment for pediatric Bell's palsy in Australasian EDs is inconsistent.
  • Prednisolone is frequently used despite limited high-level pediatric evidence.
  • The study supports the feasibility of conducting an RCT to evaluate prednisolone for pediatric Bell's palsy.
Abstract

Related Concept Videos